BioNTech AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:BioNTech AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011895
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioNTech AG (BioNTech) is a biotech company that develops biomarker based diagnostics. The company’s products include RNXtract and mammatyper, and cell and gene therapies. It pipeline products include BioNTech mRNA pharmaceuticals, BioNTech cell and gene, and BioNTech protein therapeutics. BioNTech’s technology platforms comprises ribological, ribotransporter and unicell. The company provides products in oncology therapy areas such as melanoma, breast cancer, glioblastoma and ovarian cancer; and other areas including infectious diseases, allergies, and autoimmune disorders. It operates a research and development facility in Germany. BioNTech is headquartered in Mainz, Germany.

BioNTech AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioNTech AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioNTech AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioNTech AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioNTech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BioNTech AG, Medical Devices Deals, 2011 to YTD 2017 9
BioNTech AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
BioNTech AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
MAB Discovery Enters into Agreement with BioNTech 11
BioNTech Enters into Agreement with Genentech 12
PCI Biotech Enters into Research Agreement with BioNTech 13
Eli Lilly Enters into Research Agreement with BioNTech 14
Plexera Biotech Enters into Distribution Agreement with JPT Peptide 15
MAB Discovery Enters into Research Agreement with BioNTech for Monoclonal Antibody Products 16
4SC Discovery Enters Into Research Agreement With Biontech 17
JPT Peptide Technologies Enters Into Agreement With Instituts Fur Medizinische Immunologie 18
Tecan Enters Into Co-Promotion Agreement With JPT Peptide Technologies For Array Products 19
4SC Enters Into Co-Development Agreement With Crelux And Ribological 20
JPT Peptide Technologies, IUCT And LEITAT Enters Into Co-Development Agreement 21
Licensing Agreements 22
BioNTech Enters into Licensing Agreement with Cellscript 22
Sanofi Enters into Licensing Agreement with BioNTech 23
4SC Discovery Enters Into Licensing Agreement With BioNTech For TLR Agonists 24
Acquisition 25
BioNTech Small Molecules Acquires 4SC Discovery from 4SC 25
BioNTech AG – Key Competitors 26
BioNTech AG – Key Employees 27
BioNTech AG – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Product News 29
06/01/2016: Nature Publication Describes First Example of a Clinically Applicable and Systemic mRNA Cancer Immunotherapy Vaccine 29
Other Significant Developments 30
Oct 04, 2017: BioNTech Manufacturing Subsidiary, EUFETS, Becomes BioNTech Innovative Manufacturing Services 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
BioNTech AG, Pharmaceuticals & Healthcare, Key Facts, 2015 2
BioNTech AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioNTech AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioNTech AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioNTech AG, Deals By Therapy Area, 2011 to YTD 2017 8
BioNTech AG, Medical Devices Deals, 2011 to YTD 2017 9
BioNTech AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MAB Discovery Enters into Agreement with BioNTech 11
BioNTech Enters into Agreement with Genentech 12
PCI Biotech Enters into Research Agreement with BioNTech 13
Eli Lilly Enters into Research Agreement with BioNTech 14
Plexera Biotech Enters into Distribution Agreement with JPT Peptide 15
MAB Discovery Enters into Research Agreement with BioNTech for Monoclonal Antibody Products 16
4SC Discovery Enters Into Research Agreement With Biontech 17
JPT Peptide Technologies Enters Into Agreement With Instituts Fur Medizinische Immunologie 18
Tecan Enters Into Co-Promotion Agreement With JPT Peptide Technologies For Array Products 19
4SC Enters Into Co-Development Agreement With Crelux And Ribological 20
JPT Peptide Technologies, IUCT And LEITAT Enters Into Co-Development Agreement 21
BioNTech Enters into Licensing Agreement with Cellscript 22
Sanofi Enters into Licensing Agreement with BioNTech 23
4SC Discovery Enters Into Licensing Agreement With BioNTech For TLR Agonists 24
BioNTech Small Molecules Acquires 4SC Discovery from 4SC 25
BioNTech AG, Key Competitors 26
BioNTech AG, Key Employees 27
BioNTech AG, Subsidiaries 28

★海外企業調査レポート[BioNTech AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Petrochemical Industries Co:企業の戦略的SWOT分析
    Petrochemical Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Ramba Energy Ltd (R14):石油・ガス:M&Aディール及び事業提携情報
    Summary Ramba Energy Ltd (Ramba Energy), a subsidiary of Redmount Holdings Ltd, is an oil and gas company that offers exploration and production of oil and gas properties in Indonesia. The company provides services such as inbound and outbound transportation activities, seaport and airport cargo han …
  • Nippon Chemiphar Co Ltd (4539):企業の財務・戦略的SWOT分析
    Summary Nippon Chemiphar Co Ltd (Nippon Chemiphar) is a provider of pharmaceutical drugs and health-related services. The company manufactures, supplies, imports and exports ethical pharmaceuticals and diagnostic agents. Nippon Chemiphar offers diagnostic products, such as IgE NC, a diagnostic kit t …
  • Koninklijke Philips N.V.:企業のM&A・事業提携・投資動向
    Koninklijke Philips N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Koninklijke Philips N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Univar Solutions Inc (UNVR):企業の財務・戦略的SWOT分析
    Univar Solutions Inc (UNVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Kumagai Gumi Co Ltd (1861):企業の財務・戦略的SWOT分析
    Kumagai Gumi Co Ltd (1861) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • icapital biz Berhad:企業の戦略・SWOT・財務情報
    icapital biz Berhad - Strategy, SWOT and Corporate Finance Report Summary icapital biz Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Medline Industries, Inc.:企業のM&A・事業提携・投資動向
    Medline Industries, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medline Industries, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Egdon Resources Plc (EDR):石油・ガス:M&Aディール及び事業提携情報
    Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East England, North West England, and Southern England, the UK. Its project site includes Wressle, No …
  • TerraForm Power Inc (TERP):電力:M&Aディール及び事業提携情報
    Summary TerraForm Power Inc (TerraForm Power), formerly SunEdison Yieldco Inc, a subsidiary of Brookfield Asset Management Inc, is an energy development company that owns and operates energy power plants. The company generates and distributes renewable energy by utilizing various clean power generat …
  • Mondelez International Inc (MDLZ):企業の財務・戦略的SWOT分析
    Mondelez International Inc (MDLZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Questerre Energy Corp (QEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Questerre Energy Corp (Questerre) is an independent oil and gas exploration and development company that acquires, explores, develops and produces unconventional oil and gas properties. The company’s unconventional properties include tight oil, shale oil and shale gas. It has base production …
  • Team Energy Corporation:企業の戦略的SWOT分析
    Team Energy Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Sompo Holdings, Inc. (8630):企業の財務・戦略的SWOT分析
    Sompo Holdings, Inc. (8630) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Firstmark Corporation:企業の戦略・SWOT・財務情報
    Firstmark Corporation - Strategy, SWOT and Corporate Finance Report Summary Firstmark Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Univision Communications Inc.:企業の戦略的SWOT分析
    Univision Communications Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • 3W Power S.A. (3W9K):企業の財務・戦略的SWOT分析
    3W Power S.A. (3W9K) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Indiana Resources Limited:企業の戦略・SWOT・財務情報
    Indiana Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Indiana Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Berlin Packaging, LLC.:企業の戦略・SWOT・財務情報
    Berlin Packaging, LLC. - Strategy, SWOT and Corporate Finance Report Summary Berlin Packaging, LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Texas A&M University-製薬・医療分野:企業M&A・提携分析
    Summary Texas A&M University (TAMU) is a research based university that offers educational and research services. The university provides undergraduate, graduate and professional courses to its students. It consists of various colleges and departments such as College of Agriculture and Life Sciences …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆